Glycine,N,N'-[[5-[1,12,15,26-tetraoxo-13-[[(1-oxohexadecyl)amino]methyl]-28-(1-pyrenyl)-5,8-dioxa-2,11,14,27-tetraazaoctacos-1-yl]-1,3-phenylene]bis(methylene)]bis[N-(carboxymethyl)- (494769-50-5)

Identification
Name:	Glycine,N,N'-[[5-[1,12,15,26-tetraoxo-13-[[(1-oxohexadecyl)amino]methyl]-28-(1-pyrenyl)-5,8-dioxa-2,11,14,27-tetraazaoctacos-1-yl]-1,3-phenylene]bis(methylene)]bis[N-(carboxymethyl)-
CAS:	494769-50-5
Molecular Formula:	C₇₁H₁₀₁N₇O₁₅
Molecular Structure:
Properties
Safety Data

Other Product

Glycine,N,N'-[[5-[1,12,15,26-tetraoxo-13-[[(1-oxohexadecyl)amino]methyl]-28-(1-pyrenyl)-5,8-dioxa-2,11,14,27-tetraazaoctacos-1-yl]-1,3-phenylene]bis(methylene)]bis[N-(2-ethoxy-2-oxoethyl)-, diethyl ester
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
Glycine,N,N'-[(3-oxo-1(3H)-isobenzofuranylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[N-(carboxymethyl)-
21,24-Dioxa-2,15,18,27,30,33,36-heptaazaoctatriacontan-38-oic acid,30,33,36-tris(carboxymethyl)-3,14,17,28-tetraoxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-
1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
21,24-Dioxa-2,15,18,27-tetraazanonacosan-29-oic acid,27-(carboxymethyl)-3,14,17-trioxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-
1/C30H52/c1-10-25(6)16-12-20-30(9,21-13-17-26(7)15-11-14-23(2)3)29-22-27(8)18-19-28(29)24(4)5/h10,17,22-23,25,28-29H,1,4,11-16,18-21H2,2-3,5-9H3/b26-17
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
Glycine,N,N'-[(3-oxo-1(3H)-isobenzofuranylidene)bis[[6-hydroxy-2-methyl-5-(1-methylethyl)-3,1-phenylene]methylene]]bis[N-(carboxymethyl)-
Glycine,N,N'-[(3-oxo-1(3H)-isobenzofuranylidene)bis[[6-hydroxy-2-methyl-5-(1-methylethyl)-3,1-phenylene]methylene]]bis[N-(carboxymethyl)-,disodium salt (9CI)
Glycine,N,N'-[(3-oxo-1(3H)-isobenzofuranylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[N-(carboxymethyl)-,sodium salt (1:2)
21,24-Dioxa-2,15,18,27,30,33-hexaazapentatriacontan-35-oic acid,30,33-bis(2-ethoxy-2-oxoethyl)-3,14,17,28-tetraoxo-16-[[(1-oxohexadecyl)amino]methyl]-1-(1-pyrenyl)-, ethyl ester
1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
Glycine,N,N'-[(1,1-dioxido-3H-2,1-benzoxathiol-3-ylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[N-(carboxymethyl)-,sodium salt (1:1)
Formamide,N-[11-((15-hydroxy-9-methoxy-10,20-dimethyl-6,8,11,17-tetraoxo-3,18,26-trioxa-7,28,29-triazatricyclo[23.2.1.12,5]nonacosa-2(29),4,12,23,25(28),27-hexaen-19-yl))-4,10-dimethoxy-5,9-dimethyl-6-oxo-1-undecen-1-yl]-N-methyl-,(-)-
Glycine,N,N'-[(1,1-dioxido-3H-2,1-benzoxathiol-3-ylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[N-(carboxymethyl)-,sodium salt (1:?)
Glycine,N,N'-[(1,1-dioxido-3H-2,1-benzoxathiol-3-ylidene)bis[(6-hydroxy-5-methyl-3,1-phenylene)methylene]]bis[N-(carboxymethyl)-,sodium salt (1:4)
1/C15H11Br/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-9H,10H